# FDA Inspection 663882 - CHI Baylor St. Luke's Medical Center - May 25, 2010

Source: https://www.keypedia.com/records/fda_inspections/chi-baylor-st-lukes-medical-center/a7c4ba75-8a90-43b2-8533-cd7f4c237b2d
Source feed: FDA_Inspections

> FDA Inspection 663882 for CHI Baylor St. Luke's Medical Center on May 25, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 663882
- Company Name: CHI Baylor St. Luke's Medical Center
- Inspection Date: 2010-05-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 885586 - 2014-07-01](https://www.keypedia.com/records/fda_inspections/chi-baylor-st-lukes-medical-center/296b8a65-32af-461c-852d-dec96529a275)
- [FDA Inspection 778593 - 2012-04-18](https://www.keypedia.com/records/fda_inspections/chi-baylor-st-lukes-medical-center/25fd1383-97ec-41ed-bc87-50b3b7649770)

Company: https://www.keypedia.com/companies/chi-baylor-st-lukes-medical-center/e25b32ad-4492-47eb-9083-4122e5ed5f15

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d